Jason C. Ye

Jason C. Ye

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2015 in Clinical Breast Cancer
Verified
Journal Article
Closed access
JYJason C. Ye
Jason C. Ye
WYWeisi Yan
Weisi Yan
PCPaul J. Christos
Paul J. Christos
DNDattatreyudu Nori
Dattatreyudu Nori
ARAkkamma Ravi
Akkamma Ravi

1 June 2015 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
JYJason C. Ye
Jason C. Ye
PMPranshu Mohindra
Pranshu Mohindra
ASAlexander Spektor
Alexander Spektor
MKMonica S. Krishnan
Monica S. Krishnan
SCSteven J. Chmura
Steven J. Chmura
DGDaniel W. Golden
Daniel W. Golden

1 January 2020 in Seminars in Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
JYJason C. Ye
Jason C. Ye
LDLi Ding
Li Ding
SAScott M. Atay
Scott M. Atay
JNJorge J. Nieva
Jorge J. Nieva
PMP. Michael McFadden
P. Michael McFadden
AKAnthony W. Kim
Anthony W. Kim

1 February 2015 in Clinical Breast Cancer
Verified
Journal Article
Closed access
JYJason C. Ye
Jason C. Ye
WYWeisi Yan
Weisi Yan
PCPaul Christos
Paul Christos
DNDattatreyudu Nori
Dattatreyudu Nori
KCKun-San C. Chao
Kun-San C. Chao
ARAkkamma Ravi
Akkamma Ravi

1 October 2015
Verified
Journal Article
Open access
PDF file
JYJason C. Ye
Jason C. Ye
MQMuhammad M. Qureshi
Muhammad M. Qureshi
PCPauline Clancy
Pauline Clancy
LDLauren N. Dise
Lauren N. Dise
JWJohn Willins
John Willins
AHAriel E. Hirsch
Ariel E. Hirsch
Daily patient setup error in prostate image guided radiation therapy with fiducial-based kilovoltage onboard imaging and conebeam computed tomography

10 March 2022 in American Journal of Clinical Oncology
Verified
Journal Article
Closed access
JJJulie K. Jang
Julie K. Jang
SAScott M. Atay
Scott M. Atay
LDLi Ding
Li Ding
EDElizabeth A. David
Elizabeth A. David
SWSean C. Wightman
Sean C. Wightman
JYJason C. Ye
Jason C. Ye
Objective: As stereotactic body radiation therapy (SBRT) becomes widely available for early-stage non–small cell lung cancer (NSCLC), there may be concerns in the surgical community that SBRT is being offered for patients with operable tumors, even though surgery is standard of care. We evaluated the trends in SBRT and surgery over time for patients with NSCLC. Materials and Methods: The National Cancer Database was queried for patients with node-negative NSCLC ≤5 cm from 2004 to 2016. The relationships between definitive local treatment modalities and year were analyzed using a multinomial regression model while controlling for other covariates. Results: Among the 202,367 patients who met the inclusion criteria, there was a steady decrease in mean tumor size in all treatment modalities, from 2.44 cm (SD=1.08) to 2.25 cm (SD=1.00) over the study period. In the multinomial model, the probability of receiving lobectomy demonstrated a slight decline from 58% (2004) to 53% (2016). The use of SBRT increased from 1% to 20%, while patients receiving no therapy declined from 27% to 16%. The likelihood of SBRT increased with year of diagnosis (P<0.0001) and decreasing tumor size (P<0.0001), compared with lobectomy. Age, race, income, facility, and Charlson-Deyo score were also associated with treatment modality. Conclusions: The mean tumor size of early-stage NSCLC decreased over the study period for all treatment modalities. SBRT use has increased, mostly among older patients with smaller tumors and Charlson-Deyo scores ≥3. The increase in SBRT contributed to the significant decline in patients who had no therapy.